Haemodynamic parameters
| BVS (n=8) | BP-EES (n=10) | PP-EES (n=10) | P value | |
| Baseline | ||||
| Heart rate (bpm) | 68±13 | 71±16 | 66±6 | 0.02 |
| DBP (mm Hg) | 86±18 | 84±14 | 81±14 | 0.66 |
| SBP (mm Hg) | 155±22 | 142±26 | 138±28 | 0.84 |
| 50 W | ||||
| Heart rate (bpm) | 96±15 | 95±18 | 92±12 | 0.51 |
| DBP (mm Hg) | 98±24 | 104±21 | 92±22 | 0.44 |
| SBP (mm Hg) | 156±27 | 174±38 | 163±31 | 0.64 |
| RPP | 15 094±4023 | 16 969±5357 | 14 889±4603 | 0.74 |
| 100 W | ||||
| Heart rate (bpm) | 104±24 | 123±32 | 99±13 | 0.13 |
| DBP (mm Hg) | 94±26 | 108±27 | 92±30 | 0.35 |
| SBP (mm Hg) | 163±31 | 182±37 | 171±23 | 0.45 |
| RPP | 17 371±6538 | 22 142±5895 | 16 745±2679 | 0.11 |
| RPP>20 000, n (%) | 2 (25) | 6 (60) | 1 (10) | 0.14 |
| After nitroglycerin | ||||
| Heart rate (bpm) | 83±10 | 86±17 | 73±12 | 0.16 |
| DBP (mm Hg) | 84±15 | 84±19 | 73±17 | 0.32 |
| SBP (mm Hg) | 131±23 | 136±27 | 118±18 | 0.29 |
Values are expressed as mean ±SD .
BP-EES, bioabsorbable polymer everolimus-eluting stent; BVS, biovascular scaffolds; DBP, diastolic blood pressure; PP-EES, persistent polymer everolimus-eluting stent; RPP, rate pressure product in mm Hg * bpm; SBP, systolic blood pressure.